Di Sabatino Antonio - Dipartimento di Medicina interna e terapia medica

Utility

Invia ad un amico

Antonio Di Sabatino

Professore Ordinario di Medicina Interna - Vice Direttore del Dipartimento - Direttore dell'Unità

Sede:

Unità di Medicina Interna e Gastroenterologia- Clinica Medica I c/o Policlinico San Matteo, Piazzale Golgi 19, Pavia

Telefono	+ 39 0382 502973
Fax	+ 39 0382 502618
E-mail	a.disabatino@smatteo.pv.it
Insegnamenti	Clinical Medicine 2 , Medicine & Surgery - Harvey Course Clinica Medica 2, Facoltà di Medicina e Chirurgia - Corso Golgi Digestive System Diseases - Medicine & Surgery - Harvey Course Semeiotica Medica e Metodologia Clinica - Facoltà di Medicina e Chirurgia - Corso Golgi Gastroenterologia - Scuola di Specializzazione in Gastroenterologia Medicina Interna - Scuola di Specializzazione in Gastroenterologia Gastroenterologia - Scuola di Specializzazione in Medicina Interna Medicina Interna - Scuola di Specializzazione in Medicina Interna
Pubblicazioni	Vanoli A, Di Sabatino A, Martino M et al. Small bowel carcinomas in celiac or Crohn's disease: distinctive histophenotypic, molecular and histogenetic patterns. Mod Pathol. 2017; 30(10):1453-1466. Di Sabatino A, Corazza GR. Epitope-specific immunotherapy: a vaccine for coeliac disease? Lancet Gastroenterol Hepatol. 2017;2(7):464-465. Vanoli A, Di Sabatino A, Furlan D et al. Small bowel carcinomas in coeliac or Crohn's disease: clinico-pathological, molecular, and prognostic features. A Study From the Small Bowel Cancer Italian Consortium. J Crohns Colitis. 2017;11(8):942-953. Di Sabatino A, Vanoli A, Invernizzi R, Corazza GR. Spleen hypofunction in eosinophilic gastrointestinal disease. Br J Haematol. 2017; 176(4):513. Rieder F, Latella G, Magro F, Yuksel ES, Higgins PD, Di Sabatino A, de Bruyn JR, Rimola J, Brito J, Bettenworth D, van Assche G, Bemelman W, d'Hoore A, Pellino G, Dignass AU. European Crohn's and Colitis Organisation Topical Review on Prediction, Diagnosis and Management of Fibrostenosing Crohn's Disease. J Crohns Colitis. 2016;10(8):873-885. Spadoni I, Zagato E, Bertocchi A, Paolinelli R, Hot E, Di Sabatino A et al. A Gut-vascular barrier controls the systemic dissemination of bacteria. Science 2015;350(6262):830-834. Biancheri P, Brezski RJ, Di Sabatino A et al. Proteolytic cleavage and loss of function of biologic agents that neutralize tumor necrosis factor in the mucosa of patients with inflammatory bowel disease. Gastroenterology 2015;149(6):1564-1574. Biancheri P, Di Sabatino A, Rescigno M et al. Abnormal thymic stromal lymphopoietin expression in the duodenal mucosa of patients with coeliac disease. Gut 2015;65(10):1670-1680. Monteleone G, Neurath MF, Ardizzone S, Di Sabatino A et al. A phase II, randomized, double-blind, placebo-controlled trial of Mongersen, a Smad7 antisense oligonucleotide, in patients with Crohn’s disease. N Engl J Med 2015;372(12):1104-1113. Di Sabatino A, Volta U, Salvatore C et al. Small Amounts of Gluten in Subjects With Suspected Nonceliac Gluten Sensitivity: A Randomized, Double-Blind, Placebo-Controlled, Cross-Over Trial. Clin Gastroenterol Hepatol. 2015;13(9):1604-1612. Di Sabatino A, Giuffrida P, Vanoli A et al. Increase in neuroendocrine cells in the duodenal mucosa of patients with refractory celiac disease. Am J Gastroenterol 2014;109(2):258-269. Biancheri P, Di Sabatino A, Ammoscato F et al. Absence of a role for interleukin-13 in inflammatory bowel disease. Eur J Immunol 2014;44(2):370-385. Di Sabatino A, Corazza GR. Nonceliac gluten sensitivity: sense or sensibility? Ann Intern Med 2012;156(4):309-311. Di Sabatino A, Biagi F, Gobbi PG, Corazza GR. How I treat enteropathy-associated T-cell lymphoma. Blood 2012;119:2458-2468. Di Sabatino A, Rovedatti L, Vetrano S et al. Involvement of CD40-CD40 ligand in uncomplicated and refractory celiac disease. Am J Gastroenterol 2011;106(3):519-527. Di Sabatino A, Carsetti R, Corazza GR. Post-splenectomy and hyposlenic states. Lancet 2011;378(9785):86-97. Di Sabatino A, Battista N, Biancheri P et al. The endogenous cannabinoid system in the gut of patients with inflammatory bowel disease. Mucosal Immunol 2011;4(5):574-583. Di Sabatino A, Rovedatti L, Kaur R et al. Targeting gut T cell Ca2+ release-activated Ca2+ channels inhibits Th1 cytokine production and T-box transcription factor T-bet in inflammatory bowel disease. J Immunol 2009;183(5):3454-3462. Rescigno M, Di Sabatino A. Dendritic cells in intestinal homeostasis and disease. J Clin Invest 2009;119(9):2441-2450. Di Sabatino A, Corazza GR. Coeliac disease. Lancet 2009;373(9673):1480-1493. Di Sabatino A, Jackson CL, Pickard KM et al. Transforming growth factor-b signalling and matrix metalloproteinases in the mucosa overlying Crohn’s disease strictures. Gut 2009;58(6):777-789. Di Sabatino A, Pickard KM, Rampton D et al. Blockade of transforming growth factor-b up-regulates T-box transcription factor T-bet, and increases T helper cell type 1 cytokine and matrix metalloproteinase-3 production in the human gut mucosa. Gut 2008;57(5):605-612. Di Sabatino A, Pender SLF, Jackson CL et al. Functional modulation of Crohn’s disease myofibroblasts by anti-TNF antibodies. Gastroenterology 2007;133(1):137-149. Di Sabatino A, Pickard KM, Gordon JN et al. Evidence for the role of interferon-alfa production by dendritic cells in the Th1 response in celiac disease. Gastroenterology 2007;133(4):1175-1187. Di Sabatino A, Rosado MM, Cazzola P et al. Splenic hypofunction and the spectrum of autoimmune and malignant complications in celiac disease. Clin Gastroenterol Hepatol 2006;4(2):179-186. Di Sabatino A, Ciccocioppo R, Cupelli F et al. Epithelium-derived interleukin-15 regulates intraepithelial lymphocyte Th1 cytokine production, cytotoxicity and survival in coeliac disease. Gut 2006;55(4):469-477.